Literature DB >> 2137157

Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system.

M J Flaherty1, S West, R L Heimark, K Fujikawa, J F Tait.   

Abstract

Placental anticoagulant protein-I (PAP-I), a member of the lipocortin protein family, is a potent in vitro anticoagulant whose in vivo function is unknown. Very low levels of PAP-I were present in plasma of normal volunteers (0 to 5 ng/ml) and in randomly chosen plasma specimens from hospitalized patients (0 to 28 ng/ml). Review of selected hospital records did not reveal any single clinical entity that correlated with plasma levels. PAP-I was also found in amniotic fluid (12 to 107 ng/ml) and in conditioned medium of cultured endothelial cells (49 +/- 20 ng/ml). Gel filtration experiments showed that PAP-I was intact and uncomplexed in plasma and amniotic fluid. The protein was fairly abundant intracellularly: 4080 +/- 2560 ng/mg total protein in cultured umbilical vein endothelial cells; 178 +/- 109 ng/mg in platelets; 564 +/- 384 ng/mg in leukocytes; and 8.4 +/- 4.3 ng/mg in erythrocytes. The levels of PAP-I increased in platelet-rich plasma after stimulation of platelets with arachidonic acid but not after stimulation with ADP, epinephrine, thrombin, ristocetin, or collagen. These data suggest that PAP-I probably does not function as a circulating natural anticoagulant in normal persons.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137157

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  20 in total

1.  An αIIbβ3- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis.

Authors:  Jian Jing; Yanna Sun
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

Review 2.  Annexins: calcium-binding proteins of multi-functional importance?

Authors:  J Römisch; E P Pâques
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

3.  Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins.

Authors:  D A Eberhard; S R Vandenberg
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Relocation of annexin V to platelet membranes is a phosphorylation-dependent process.

Authors:  P J Trotter; M A Orchard; J H Walker
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Antiannexin V autoantibody in thrombophilic Behçet's disease.

Authors:  H Aslan; S Pay; F Gok; Y Baykal; M I Yilmaz; A Sengul; H I Aydin
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

6.  Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Pojen P Chen; Keith R McCrae; Edwin G Bovill; Douglas J Taatjes
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.

Authors:  L R Sammaritano; A E Gharavi; C Soberano; R A Levy; M D Lockshin
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

8.  Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells.

Authors:  P Raynal; F Hullin; J M Ragab-Thomas; J Fauvel; H Chap
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

9.  Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.

Authors:  P M Sandset; B J Warn-Cramer; L V Rao; S L Maki; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine.

Authors:  Christina Smith; Donald F Gibson; Jonathan F Tait
Journal:  BMC Biochem       Date:  2009-02-17       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.